Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000886163-20-000076
Filing Date
2020-06-12
Accepted
2020-06-12 18:33:53
Documents
1
Period of Report
2020-06-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 5659
  Complete submission text file 0000886163-20-000076.txt   7030
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Issuer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10275 SCIENCE CENTER DR SAN DIEGO CA 92121
Business Address
KOZARICH JOHN W (Reporting) CIK: 0001223000 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33093 | Film No.: 20961487